Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Lymphoseek, tilmanocept
Also known as: 99mTc-DTPA (formerly Mannosyl-Dextran)
print preview
bookmark
share with colleague
General Information
Company
Navidea Biopharmaceuticals Inc.
Description
Radioisotope technetium-99m that binds to mannose binding receptor (MBR; CD206) proteins on the surface of immune cells
Molecular Target
Mannose binding receptor (MBR) (CD206)
Mechanism of Action
Diagnostic; Imaging agent
Latest Stage of Development
Marketed
Indication
Cancer, Diagnostic
Partner
Cardinal Health Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy